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Summary 
Surface IgM (slgM) stimulation induces the tyrosine phosphorylation of multiple cellular sub- 
strates,  including phospholipase C  (PLC)-'~/2,  which is involved in the activation ofphosphati- 
dyhnositol pathway.  DT40 B  cells  underwent apoptotic  cell death when  activated through 
slgM, a phenomenon that is related to elimination of  self-reactive B cells. To examine the roles 
of PLC-~/2 in slgM signaling,  we have generated DT40 cells deficient in PLC-y2 Cross-link- 
ing ofslgM on PLC-y2-deficient cells evoked neither inositol 1,4,5-trisphosphate nor calcium 
mobilization.  In  PLC-T2-  or  Syk-deficient  DT40  cells,  the  induction  of apoptosis  was 
blocked, but was  still  observed in  Lyn-deficient cells.  Src homology 2  domains  of PLC-T2 
were essential  for both its activation and slgM-induced apoptosis. Since tyrosine phosphoryla- 
tion of PLC-T2 is mediated by Syk, these results  indicate that activation of PLC-T2 through 
Syk is required for slgM-induced apoptosis. 
S 
timulation of surface IgM (slgM) 1 on B cells by antigen 
or anti-IgM antibody initiates a cascade of biochemical 
events including protein tyrosine kinase  (PTK) activation, 
phosphatidylinositol (Ptdlns) hydrolysis, and calcium mobi- 
lization (for review see references 1-6). Functional analysis 
of the intracytoplasmic domains of Igor and Ig]3, which are 
subunits of the slgM complex, revealed that an  18-amino 
acid motif based on a tandem YXXL stretch,  the immu- 
noreceptor tyrosine-based activation motif (ITAM),  cou- 
ples the slgM  complex to these early signaling events (7- 
11).  Two  types  of PTKs,  Src-PTK and  Syk kinase,  are 
shown to associate  with the slgM  complex through Iget/ 
Ig]3 heterodimer  (12-22).  It  has  also  been  demonstrated 
that both Src-PTK and Syk are required for coupling slgM 
to  the  induction of protein tyrosine phosphorylation and 
that these enzymes mediate the phosphorylation of at least 
partially distinct sets  of substrates  (23).  One  of the  phos- 
phorylated substrates  mediated by Syk is phospholipase  C 
(PLC)-y2 (23-28). Phosphorylation of  PLC-'y2 is responsi- 
ble for an increase in its catalytic activity (29, 30). Activated 
PLC-~/2 catalyzes the hydrolysis ofphosphoinositides, lead- 
ing to the generation of second messengers, inositol 1,4,5- 
trisphosphate (InsP3) and diacylglycerol (31, 32). 
Calcium mobilization induced by slgM ligation is a bi- 
phasic response composed of an initial release of internally 
1Abbreviations used in this paper: InsP3, inositol 1,4,5-trisphosphate; Ptdlns, 
phosphatidylinositol; PLC, phosphohpase C; PTK, protein tyrosine ki- 
nase; SH2, Src homology  2; slgM, surface  immunoglobulin  M. 
stored calcium, and a subsequent entry of extracellular cal- 
cium (31, 33). Although it is widely accepted that InsP  3 
is  involved  in  release  from  intracellular  calcium  stores 
through binding to its receptor, it has not been well estab- 
lished that the calcium influx is also a downstream event of 
PLC-y2 activation (34). 
To avoid production of autoantibodies, two key censor- 
ing  mechanisms  are  known  to  operate  in  B  lymphocyte 
repertoires: functional silencing of self-reactive ceils, termed 
ctonal anergy, and physical elimination of  stir-reactive cells, 
termed clonal deletion  (for review see references 35-37). 
The existence of such an irreversible censoring mechanism 
(clonal deletion) was first suggested by the failure of a ma- 
ture  B  cell  repertoire  to  develop  in  chickens  and  mice 
treated from hatching or birth with antibodies to IgM (38). 
Elimination of B  cells bearing self-reactive Ig molecules 
is initiated by the binding of self antigens to slgM on im- 
mature B cells. Indeed, cross-linking of slgM on immature 
B  cell lines such as WEHI-231  induces apoptosis (39-47). 
However,  it  has  not  been  elucidated which  of the  early 
biochemical signals are critical for inducing apoptosis upon 
slgM cross-linking. 
We have previously established Lyn- and Syk-deficient 
cells  from  chicken  DT40  B  cell  line  by  gene  targeting, 
exploiting unusually high homologous recombination pro- 
ficiency of this  cell line  (23,  48).  To  further dissect  the 
pathways downstream of PTK activation in slgM signaling, 
we  established  a  mutant  B  cell  line  that  lacks  PLC-y2. 
Upon slgM cross-linking,  PLC-',/2-deficient cells completely 
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transfection of the  PLC-~/2  cDNA with Src  homology 2 
(SH2)  mutations, we show that the SH2-phosphotyrosine 
interaction is  essential for PLC-y2 activation in sIgM fig- 
naling. Moreover,  our results clearly indicate the require- 
ment of PLC-y2 activation for sIgM-induced apoptosis. 
Materials  and Methods 
Cells, Expression Constructs, and Antibodies.  Wild-type and var- 
ious mutant DT40 cells were maintained in RPMI 1640 supple- 
mented with 10% FCS, penicillin, streptomycin, and glutamine. 
Construction of chicken expression  vector pApuro was  already 
described (23). Mutations in SH2 domains of rat PLC-~,2 cDNA 
were created by PCR. The resulting constructs  were confirmed 
by DNA  sequencing. The mutant and wild-type PLC-3'2  (24) 
and M1  muscarinic receptor  (49) cDNAs were  subcloned into 
pApuro vector and were  electroporated  into PLC-~/2-deficient 
DT40 cells. Selection was performed in the presence  ofpuromy- 
cin (0.5 ~g/ml). Expression of transfected cDNAs was confirmed 
by Western blot analysis (PLC-y2) or binding assay (M1 muscar- 
inic  receptor).  Anti-chicken IgM  mAb  M4  (50) and  anti-rat 
PLC-'y2  antisera  (51) were  already  described.  Antiphosphoty- 
rosine mAb 4G10  was  purchased  from Upstate  Biotechnology 
Inc. (Lake Placid, NY). 
Generation of PLC-y2-de_ficient DT40 Cells.  Chicken PLC-2/2 
and PLC-2J2 cDNA clones were obtained by screening a chicken 
spleen cDNA library (Clontech Laboratories  Inc., Palo Alto, CA) 
with rat PLC-y2 cDNA under a low stringent condition. Cloned 
genomic DNA corresponding to the chicken PLC-y2 locus was 
isolated from a library of chicken liver DNA (Clontech Laborato- 
ries Inc., Palo  Alto,  CA).  The targeting vectors,  pPLC-neo and 
pPLC-hisD, were constructed by replacing the 4-kb genomic se- 
quence, which contains exons corresponding to amino acid resi- 
dues 857-947 of rat PLC-y2 cDNA, with neo or hisD cassette, 
respectively.  The upstream 1.3 kb genomic sequence was gener- 
ated by PCR using oligonucleotides containing XbaI restriction 
sites and was subcloned as an Xbal-XbaI fragment.  The upstream 
sequence was a 6.2-kb BamHI-BgllI genomic fragment,  pPLC- 
neo was linearized and transfected into DT40 cells by electropo- 
ration (550 V, 25 I.zF). G418 selection (2 mg/ml) was started 24 h 
after transfection.  Cells were cultured for N14 d, expanded,  and 
screened by  Southern blot analysis. Similarly,  pPLC-hisD  was 
transfected into neo-targeted clone, and selection was performed 
with both G418 (2 mg/ml) and histidinol (1 mg/ml). 
Western and Northern Blot Analyses.  Cells  were  solubilized in 
lysis buffer (1% NP-40,  150 mM NaC1, 20 mM Tris, pH 7.5,  1 
mM  EDTA)  containing 50  mM  NaF,  10  ~M  molybdate, 0.2 
mM sodium vanadate supplemented with protease  inhibitors (1 
mM  PMSF,  2  ~g/ml aprotinin, 0.5  mM benzamidine hydro- 
chloride,  10/~g/ml chymostatin, 0.1 mM N-o~-p-tosyl-L-lysine- 
chloromethyl  ketone,  0.1  mM N-l-tosylamide-2-phenylethylchlo- 
romethyl ketone,  10  I-tg/ml  leupeptin,  10  p~g/ml antipain,  10 
p~g/ml calpain inhibitor I, and 10 ~g/ml pepstatin). PLC-~/2 pro- 
tein was immunoprecipitated  by sequential incubation with anti- 
PLC-~/2  serum  and  protein  A-Sepharose.  Immunoprecipitates 
were resolved by SDS-PAGE, transferred to nitrocellulose mem- 
brane, and probed with antibodies.  Filters were developed with 
horseradish  peroxidase-conjugated secondary  antibodies and en- 
hanced chemiluminescence system (Amersham  Corp., Arlington 
Heights,  IL). RNA  was  prepared  from  wild-type and mutant 
DT40  cells using guanidium thiocyanate method.  Total RNA 
(20 p,g) was separated by 1.2% agarose, transferred to a Hybond- 
N  membrane, and probed with a chicken PLC-~2 cDNA frag- 
ment. 
In  Vitro PLC Assay.  PLC activity was assayed by quantitating 
InsP  3 production (27). Briefly, PLC-~2 protein was imnmnopre- 
cipitated from the transfected COS cell lysate using specific antis- 
era as described  above,  washed  extensively,  resuspended  in PLC 
assay buffer (20 mM NagPO4, pH 6.8, 70 mM KC], 0.125% oc- 
tylglucoside, 0.8 mM EGTA, 0.8 mM CaC12). Substrate contain- 
ing 5 Ci/mmol [3H]phosphatidylinositol  4,5-bisphosphate  (Am- 
ersham) was added, then reaction was allowed to proceed at 37~ 
for 30 min and was stopped by adding TCA and BSA. After cen- 
trifugation, radioactivity  in the supernatant was assayed by a liq- 
uid scintillation counter. 
Calcium Measurements.  Cells  (5  ￿  106) were  loaded  with  3 
~M fura-2/AM in PBS containing  20 mM Hepes, pH 7.2, 5 mM 
glucose, 0.025% BSA, and 1 mM CaC12 at 37~  for 45 min. Cells 
were then washed twice and adjusted to 106 cells per ml. Fluores- 
cence of the cell suspension was monitored continuously with a 
fluorescence  spectrophotometer  (F-2000;  Hitachi  Instruments, 
Inc., San Jose, CA) at an excitation wavelength of 340 nm and an 
emission wavelength of 510 nm. Calcium levels were calibrated 
and calculated as described  (52). 
PhosphoinositidesAnalysis.  Cells  (106/m])  were  labeled  with 
myo-[3H]inositol (10 btCi/rnl, 105 Ci/mmol; Amersham) for 6 h 
in  inositol-free RPMI  1640  supplemented with  10%  dialyzed 
FCS,  then stimulated with M4 mAb in the presence  of 10 mM 
LiC1. The soluble inositol phosphates  were extracted  with TCA 
at indicated time points and were applied  to AG 1-X8 (formate 
form) ion exchange columns (Bio Rad Laboratories,  Richmond, 
CA) pre-equilibrated with 0.1 M formic acid. The columns were 
washed with 10 ml water and 10 ml of 60 mM ammonium for- 
mate/5 rnM sodium tetraborate.  Elution was performed with in- 
creasing concentrations of ammonium formate  (0.1-0.7 M) (53). 
DNA Fragmentation Assay.  After  treatment  of cells with  or 
without M4  mAb,  cells (~1  X  106) were  pelleted in  1.5-ml 
tubes.  Pellets  were  gently  resuspended  in  20  p,1  of  10  mM 
EDTA/50 mM Tris-HC1,  pH 8.0, containing 0.5% sodium laur- 
ylsarkosinate and 0.5 mg/ml proteinase  K, and incubated for 2 h 
at 50~  RNaseA (10 btl, 0.5 mg/ml) was added to each sample 
and incubation was continued for an additional 2 h at 50~  Sam- 
ples were heated to 70~  and mixed with 10 ILl ofl0 mM EDTA 
containing 1%  low  melting-temperature agarose,  0.25%  bro- 
mophenol blue, and 40% sucrose before applying into 2% agarose 
gel (54). 
Flow Cytometric Analysis.  For DNA  content analysis, stimu- 
lated or unstimulated cells ('~1  X  106) were pelleted,  and resus- 
pended in 1.5 ml hypotonic DNA staining solution (50 I.zg/ml 
propidium iodide,  0.1%  sodium  citrate,  0.1%  Triton X-100). 
Samples were kept at 4~  overnight, and subjected to analysis by 
FACSort  |  (Becton Dickinson & Co., Mountain View, CA). De- 
bris and doublets were excluded by appropriate  gating (55). For 
cell surface expression  of slgM, DT40 cells were washed,  subse- 
quently incubated with FITC-conjugated anti-chicken IgM (13e- 
thyl Laboratories,  Inc., Montgomery, TX),  and analyzed  using 
FACSort. 
B(nding Assay for M I Muscarinic Receptor Expression.  Cells  (,--,1('/') 
were  incubated for  90  rain  with  muscarinic receptor  agonist 
[3H]quinuclidinyl benzilate ([3H]QNB,  100  pM,  47  Ci/mmol; 
Amersham)  at  room temperature.  After  incubation, cells were 
collected on a GF/B membrane (Whatman Inc., Clifton, NJ) and 
washed extensively. Bound radioactivity was determined by a liq- 
uid scintillation counter. All samples were assayed in duplicate, 
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of 10 ~M atropine. 
Results 
Targeted Disruption of PLC-y2.  To examine the roles of 
PLC-~/2 in sIgM signaling, we established DT40 cells defi- 
cient in PLC-y2 by gene targeting.  For disruption of the 
PLC-~/2 gene locus, the mutations of the two PLC-~/2 alle- 
les were introduced in DT40 cells  by sequential homolo- 
gous recombinations (Fig.  1, A-C).  The targeting vectors 
have  a  neomycin  or  histidinol  resistance  gene  cassette 
replacing the  chicken genomic sequence, which  contains 
exons corresponding to the region that is essential  for PLC- 
~/2 catalytic activity (Fig.  1 /3) (24).  Homologous recombi- 
nation events were screened by Southern blot analysis, and 
two independent clones beating homozygous mutations at 
the PLC-~/2 locus were identified (Fig.  1 D). Southern blot 
analysis revealed a single integration of each vector in these 
clones (data not shown). To verify null mutations, North- 
ern and Western blot analyses  using specific probes were 
carried out. Both RNA and protein expression of PLC-~/2 
were abrogated in these mutant cell clones (Fig.  1, E  and 
F). Furthermore, Northern blot analysis showed that PLC- 
2t2 is not expressed in DT40  ceils  (data  not shown).  The 
level of cell surface  expression of sIgM  on the  PLC-~/2- 
targeted clone was  essentially  the same  as that of parental 
DT40 cells (Fig. 2). 
PLC-72 Activation Is Essential  for both Ca  2+  Release  from 
Intracellular Pools and Ca  2+ Influx.  To assess the  contribu- 
tion  of PLC-~/2 to  sIgM-induced  signaling,  we first ana- 
lyzed early events in  PLC-~/2-deficient DT40  cells.  Cells 
were stimulated with anti-chicken IgM mAb (M4), and in- 
duction of protein tyrosine phosphorylation was  analyzed 
by immunoblotting with antiphosphotyrosine mAb 4G10. 
Compared with wild-type DT40,  PLC-~2-deficient cells 
showed an essentially  similar pattern of tyrosine phospho- 
rylation (Fig.  3 A), indicating that PLC-~/2 does not affect 
the  global  tyrosine phosphorylation upon  receptor cross- 
linking.  In  contrast  to  wild-type  cells,  PLC-~/2-deficient 
cells abrogated PtdIns hydrolysis upon receptor stimulation 
(Fig. 4 B), providing the direct evidence that PLC-~/2 is re- 
sponsible  for sIgM-induced  PtdIns  pathway.  In  addition, 
M4-induced  calcium  mobilization  was  completely  abol- 
ished  (Fig.  4  A).  Loss  of PLC-~/2 did  not  affect calcium 
Figure 1.  Gene targeting of the chicken PLC-'y2 locus. (A)  Partial  re- 
striction map  of PLC-~/2  locus.  (B)  Structure  of the  targeting vectors 
pPLC-~2  neo  and pPLC-hisD.  (C)  Predicted structure  of the targeted 
PLC-~/2 locus. Only the exons that are disrupted or deleted are indicated 
as black boxes. The location of the hybridization probe and expected sizes 
of the XbaI fragments that hybridize with the probe are shown. X, Xbal; 
B,  BamHI;  Bg,  BglII;  S,  SacI.  (/9)  Southern blot  analysis  of wild-type 
DT40  cells  (+/+,  lane  1),  neo-targeted cells  (+/-,  lane  2),  neo-  and 
hisD-targeted cells (-/-,  lane 3).  Genomic DNA was digested by Xbal. 
(E and F) Expression of PLC-'y2 in wild-type and targeted DT40  cells. 
(E)  PLC-~/2 protein was immunoprecipitated with anti-PLC-~/2 serum 
and was detected by Western blot analysis. Positions of molecular weight 
standards are shown. (F) RNA expression was analyzed by Northern blot 
analysis using chicken cDNA probes for PLC-~/2 (upper panel) or [3-actin 
(lowerpanei)  (56). Positions of  28S and 18S 1LNA are shown. 
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Figure 2.  Cell surface expression ofslgM on various DT40 mutant cells. 
DT40  cells were stained with FITC-conjugated anti-chicken IgM. Un- 
stained cells were used as negative controls. PLC-~2-deficient cells  ex- 
pressing wild-type and SH2  mutant of PLC-"y2  are indicated as wt/P- 
and mSH2/P-, respectively. Figure 3.  Tyrosine phosphorylation of whole-cell lysate and PLC-'y2 in 
various DT40  cells after activation with anti-IgM. (A) At the indicated 
times after the  addition of M4  (4 p~g/ml), whole-cell lysates prepared 
from 2.5 ￿  10  ~' cells were loaded onto an 8% SDS-PAGE gel. (B) PLC- 
212 was immunoprecipitated from cells (2  ￿  106 cells per lane) before 
stimulation (-) or after stimulation (+) with M4 (4 p,g/ml) for 3 min, 
and the immunoprecipitates were separated on a 6% SDS-PAGE gel.  Af- 
ter transfer to nitrocellulose, the filters were incubated with antiphospho- 
tyrosine mAb 4G10. To check the content ofPLC-'/2 (B, lower  panel), the 
filter was reprobed with anti-PLC-"/2 Ab after deprobing. 
mobilization induced by stimulation of M1  muscarinic re- 
ceptor (49),  as shown by transfectant with M1  receptor in 
PLC-y2-deficient  cells  (Fig.  4  A).  These  observations 
demonstrate  that  both  calcium  release  from  intracellular 
pools and entry across the plasma membrane are the down- 
stream events of PLC-y2 activation in slgM signaling. 
SH2  Domains  of PLC-T2  Are  Required for  its  Activation 
through slgMStimulation.  Tyrosine  kinase  growth  factor 
receptors interact with  PLC-y2 by recruiting the  enzyme 
via its SH2  domains to the tyrosine-phosphorylated recep- 
tor (57, 58). To examine the role of SH2 domains of PLC- 
"y2 in signaling responses upon  slgM stimulation, we  mu- 
tated the phosphotyrosine-binding site in the two SH2 do- 
mains  of  rat  PLC-'y2  (both  Arg  564  and  Arg  672  to  Ala; 
mSH2).  This  mutated  cDNA  was  transfected  into  PLC- 
y2-deficient DT40  cells (mSH2/P+).  As shown  in  Fig.  3 
B,  expression  extent  of mutated  PLC-'y2  was  about  the 
same level as that of the transfectant with wild-type PLC- 
~/2  (wt/P+).  In  the  transfectant  with  wild-type  PLC-y2, 
slgM-induced calcium  mobilization was  restored,  and  the 
Ptdlns hydrolysis was more vigorous than that in wild-type 
DT40  cells  (Fig.  4,  A  and  B).  This  is probably caused  by 
the  overexpression of PLC-'/2  since this hydrolysis in  an- 
other transfectant expressing lower level of wild-type PLC- 
~/2  was  less  remarkable  (data  not  shown).  In  contrast  to 
wild-type PLC-~/2, the SH2 mutant of PLC-~/2 was unable 
to  evoke both  PtdIns hydrolysis and calcium mobilization 
upon  sIgM stimulation (Fig. 4, A  and B).  The  inability of 
this  mutant  to  induce  PtdIns  hydrolysis  correlated  well 
with the mutated PLC-~/2 molecule's loss ofsIgM-induced 
tyrosine  phosphorylation  (Fig.  3  B).  Catalytic  activity of 
the  SH2  mutant  of PLC-y2  was  comparable  to  that  of 
wild-type PLC-~/2  in  COS  cells (data not  shown).  These 
observations suggest that recruitment  of PLC-~/2  to  phos- 
phorylated tyrosine via its SH2 domains is a prerequisite for 
sIgM-induced tyrosine phosphorylation of PLC-~/2. 
Activation  of PLC-y2  through Syk  Is  Required for  slgM- 
coupled Apoptosis.  It is well known  that sIgM stimulation 
eventually leads to growth inhibition and apoptosis in im- 
mature B  cell lines. Thus,  we sought to  examine whether 
sIgM  stimulation  can  induce  apoptosis  in  this  cell  line. 
Treatment of wild-type DT40 cells for 24 h  with mAb M4 
resulted in a  drastic increase of the percentage of apoptotic 
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Figure 4.  Early  signaling  events 
in wild-type  and mutant  DT40 
cells. (A)  lntracellular free cal- 
cium mobilization, fura-2-1oaded 
cells were monitored  by a spec- 
trophotometer  upon  stimulation 
with M4 (2 p,g/ml) or carbachol 
(500 p~M). Arrows indicate time 
points at which  stimulants were 
added.  PLC-~2-deficient  cells 
expressing  M1 muscarinic recep- 
tor are indicated as M1/P-.  (B) 
InsP  3 generation. Soluble inositol 
were extracted from cells stimu- 
lated with  M4  and  were  sepa- 
rated  by  AG1-X8  anion  ex- 
change columns. Data are shown 
as fold increase of the value be- 
fore stimulation  with M4. 
910  Role ofPhospholipase C-~2 in Surface Immunoglobulin M Signaling Ab  --  + 
DT40 
33  % 
~  713% 
-  § 
mSH2/P  - 
s)4<-  ~ 
25% 
S13% 
Fluorescence  Intensity 
Figure  5.  Induction of apoptosis in wild-type and mutant DT40 cells. 
Cells were cultured with (+)  or without (-) M4  (10 I~g/ml, 24 h), 
treated in hypotonic  DNA staining solution containing  50 txg/rnl  propid- 
ium iodide and were subjected to analysis by FACSort  |  (Becton-  Dickin- 
son). The percentage  of fragmented  nuclei is indicated. 
cells, as assessed by propidium iodide staining and flow cy- 
tometric  analysis  (Fig.  5)  (55).  Also,  analysis  of genomic 
DNA from anti-IgM-treated DT40 cells revealed a charac- 
teristic fragmentation pattern ofnucleosomal ladder on aga- 
rose gel (data not shown). These results indicate that DT40 
cells undergo apoptosis by signaling through slgM. 
PLC-~/2-deficient DT40 cells, along with Syk- or Lyn- 
deficient cells, were treated with mAb M4 for 24 h and the 
induction of apoptosis was  analyzed.  Stimulation of Lyn- 
deficient cells with M4 induced apoptotic cell death similar 
to wild-type cells, whereas Syk- or PLC-~/2-deficient cells 
treated with M4 showed a dramatically reduced percentage 
of fragmented nuclei  (Fig.  5).  This blockade of apoptosis 
was not caused by low level expression of slgM in Syk- or 
PLC-~/2-deficient  cells  because  both  cells  expressed  the 
same level ofslgM as wild-type cells (Fig. 2). Furthermore, 
transfection of Syk or PLC-~/2 cDNA into these deficient 
cells restored the defect (Fig. 5 and data not shown). 
Since the SH2 domains of PLC-~/2 are essential  for Syk- 
mediated PLC-~/2 activation in slgM signaling,  we exam- 
ined the effect of the SH2 mutation on slgM-induced apo- 
ptosis.  Similar to  PLC-~/2-deficient cells,  cells  expressing 
the SH2 mutant of PLC-~/2 showed the blockade of slgM- 
induced  apoptosis  (mSH2/P +  in  Fig.  5).  These  observa- 
tions demonstrate that activation of PLC-'y2 through Syk is 
critical for slgM-induced apoptosis. 
Discussion 
Lyn- or Syk-deficient DT40 cells respond to slgM stimula- 
tion  with  a  limited  tyrosine  phosphorylation  of cellular 
substrates  (23),  whereas  PLC-~/2-deficient cells  exhibited 
almost the same pattern of tyrosine phosphorylation as the 
wild-  type cells  upon slgM  cross-linking (Fig.  3 A).  This 
observation, together with the evidence that slgM-induced 
tyrosine phosphorylation of PLC-~2 is dependent on Syk 
(23),  supports  the  concept  that  PLC-~2  activation  is  a 
downstream event of PTK activation in slgM signaling. 
Experiments in which PLC-~/2 cDNA with SH2 muta- 
tions was introduced into PLC-~/2-deficient cells demon- 
strate  that  the  SH2  domains  are  critical for activation of 
PLC-~/2 through sIgM.  Since slgM-induced phosphoryla- 
tion of PLC-~2 was also abolished in this SH2 mutant (Fig. 
3  B),  it appears that SH2-phosphotyrosine interaction is a 
prerequisite for phosphorylation of PLC-~/2. These obser- 
vations raise  the possibility that, as in the case of receptor 
tyrosine kinase signaling (57,  58), PLC-~/2 is recruited via 
its SH2 domains to inducibly phosphorylated proteins such 
as slgM complex or associated PTKs. Indeed, various phos- 
phoproteins,  including  Src-PTKs,  are  shown  to  associate 
with  SH2  domains  of PLC-~2  isoform in  vitro  (59-64). 
Because  tyrosine  phosphorylation  of PLC-~2  is  still  in- 
duced  by  slgM  stimulation  in  Lyn-deficient DT40  cells 
(23),  candidates  to  which  PLC-~/2  is  recruited  include 
those  inducibly phosphorylated proteins  in  Lyn-deficient 
cells. 
Rapid calcium mobilization following slgM stimulation 
presents two phases:  the initial phase consists  of a transient 
release of calcium from intracellular stores and is followed 
by a sustained calcium influx caused by the opening of the 
calcium channels present in the plasma membrane (31, 33). 
Although it has been well established that InsP  3 is primarily 
responsible for mobilizing calcium from intracellular stor- 
age  sites  through  binding  to  its  receptor,  the  regulatory 
mechanisms for calcium entry are less clear (34).  The pre- 
vailing hypothesis is  that calcium entry is somehow cou- 
pled to the InsP3-induced depletion ofintracellular calcium 
stores,  a  process  termed  capacitative  calcium  entry.  The 
most compelling evidence for this hypothesis comes from 
the observation that inducers of intracellular calcium pool 
depletion, such as thapsigargin, mimic the ability of surface 
receptors  to  activate  calcium  entry  (33).  On  the  other 
hand,  receptor-operated calcium  mobilization  in  the  ab- 
sence of detectable Ptdlns hydrolysis have previously been 
noted in several systems,  suggesting the presence of InsP  3- 
independent  calcium entry mechanism  (65-69).  Abolish- 
ment of slgM-induced calcium mobilization in PLC-~2- 
deficient cells  (Fig.  4 A)  provides the direct evidence that 
both calcium release from endoplasmic reticulum and entry 
from outside of the cells are downstream events of PLC-~/2 
activation.  This  conclusion supports  the  capacitative  cal- 
cium  entry hypothesis,  and  the  previously observed  dis- 
crepancy might be explained by relative insensitivity of  Ptdlns 
assays. 
In  this  study,  we  have demonstrated that  activation of 
PLC-~/2  is  required  for  slgM-induced  apoptosis.  The 
blockade ofslgM-induced apoptosis in Syk-deficient DT40 
cells supports this conclusion because Syk, not Lyn, is es- 
sential for coupling slgM to the Ptdlns pathway (23).  The 
requirement  of PLC-~/2  activation  suggests  that  second 
messengers,  InsP  3 and  diacylglycerol,  as  well  as  calcium 
mobilization, are crucial for the induction of apoptosis. In- 
911  Takata  et al. deed,  sustained  calcium  elevation  has  been  implicated  in 
apoptosis  of various  cell  systems  (70,  71).  It  appears  un- 
likely, however, that these second messengers alone initiate 
apoptosis through slgM signaling.  Transfectant  with  mus- 
carinic M1 receptor in DT40 cells  cannot undergo apopto- 
sis upon carbachol stimulation despite the activation of the 
Ptdlns pathway and calcium mobilization (Takata, M.,  and 
T. Kurosaki,  unpublished  result).  An explanation is that in 
addition  to  activation  of Ptdlns  pathway,  PLC-~/2  might 
have another activity, yet undefined,  which is required for 
the induction of apoptosis.  It is also possible that slgM-in- 
duced  apoptosis  requires  another  biochemical  event(s) 
other than PLC-~/2 activation through slgM signaling.  An 
observation  that  simultaneous  stimulation  through  slgM 
and  transfected  M1  receptor  failed to induce  apoptosis  in 
PLC-'u  cells  (Takata,  M.,  and T.  Kurosaki,  un- 
published result) may support the first possibility. 
The process of apoptosis is dependent on RNA and pro- 
tein  synthesis,  leading  to  the  concept  of death  genes  that 
are responsible for the phenomena (72, 73). Recently, sev- 
eral  genes  implicated  in  apoptosis  of different  cell  types 
have been  identified,  including  c-myc  (47,  74,  75),  nur77 
(76,  77),  bd-2  (45,  78-82),  bd-x  (83),  and  bax  (84).  Thus, 
understanding  the  relationship  between  early  signaling 
events  and  regulation  of these  genes  should  elucidate  the 
mechanisms ofsIgM-induced B cell apoptosis. 
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